PMVP PMV Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1699382 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.52M 1 sales by 1 insiders
- Filings on record
- 108 since 2021-07-08, latest 2026-06-05 16:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| OrbiMed Capital GP V LLC | 10% | — | $1.52M |
| Mack David Henry | Pres, CEO, Dir | — | — |
Transactions 72
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-29 | 2025-10-27 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $1.37 | +220.6K | 451.1K | +96% | +$302.3K |
| I | 2025-10-27 | 2025-10-23 | PMVP | OrbiMed Capital GP V LLC | 10% | S - Sale | $1.52 | -1.00M | 4.98M | -17% | -$1.52M |
| I | 2025-09-12 | 2025-09-10 | PMVP | ORBIMED ADVISORS LLC | 10% | S - Sale | $1.80 | -500.0K | 5.98M | -8% | -$900.0K |
| 2025-07-03 | 2025-07-01 | PMVP | Carulli Michael | CFO | S - Sale | $1.06 | -28.2K | 60.1K | -32% | -$29.9K | |
| 2025-07-03 | 2025-07-01 | PMVP | Jalota Deepika | Chief Development Off | S - Sale | $1.06 | -33.1K | 90.0K | -27% | -$35.0K | |
| 2025-07-03 | 2025-07-01 | PMVP | Mack David Henry | Pres, CEO, Dir | S - Sale | $1.06 | -58.4K | 536.1K | -10% | -$61.9K | |
| 2025-07-03 | 2025-07-01 | PMVP | Ticktin Robert | GC, COO | S - Sale | $1.06 | -23.2K | 98.7K | -19% | -$24.5K | |
| DM | 2025-01-22 | 2024-12-03+ | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +109.5K | 551.9K | +25% | +$58.0K |
| 2024-09-12 | 2024-09-11 | PMVP | Carulli Michael | CFO | S - Sale | $1.50 | -2,891 | 88.4K | -3% | -$4,336 | |
| 2024-09-12 | 2024-09-11 | PMVP | Jalota Deepika | Chief Development Off | S - Sale | $1.50 | -7,218 | 118.3K | -6% | -$10.8K | |
| D | 2024-01-22 | 2024-01-18 | PMVP | Carulli Michael | CFO | A - Grant | $0.00 | +82.2K | 91.3K | +907% | $0 |
| D | 2024-01-22 | 2024-01-18 | PMVP | Mack David Henry | Pres, CEO, Dir | A - Grant | $0.00 | +163.9K | 442.5K | +59% | $0 |
| D | 2024-01-22 | 2024-01-18 | PMVP | Jalota Deepika | Chief Development Off | A - Grant | $0.00 | +95.6K | 125.5K | +319% | $0 |
| I | 2023-11-24 | 2023-11-22 | PMVP | OrbiMed Genesis GP LLC | 10% | S - Sale | $2.23 | -87.8K | 0 | -100% | -$195.8K |
| D | 2023-11-13 | 2023-11-10 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | -85.3K | 278.6K | -23% | $0 |
| D | 2023-11-13 | 2023-10-18 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +198.4K | 363.9K | +120% | +$105.2K |
| DI | 2023-11-13 | 2023-11-10 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | +85.3K | 165.3K | +107% | $0 |
| 2023-09-18 | 2023-09-15 | PMVP | Alland Leila | Chief Medical Off | S - Sale | $6.62 | -6,291 | 45.9K | -12% | -$41.6K | |
| 2023-09-18 | 2023-09-15 | PMVP | Jalota Deepika | Chief Development Off | S - Sale | $6.62 | -4,104 | 29.9K | -12% | -$27.2K | |
| D | 2023-08-08 | 2023-08-07 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +85.5K | 165.5K | +107% | +$45.3K |
| 2023-01-30 | 2022-11-25 | PMVP | Kung Winston | COO, CFO | G - Gift | $0.00 | -2,560 | 10.6K | -19% | $0 | |
| 2022-09-13 | 2022-09-09 | PMVP | Alland Leila | Chief Medical Off | A - Grant | $0.00 | +52.2K | 52.2K | New | $0 | |
| 2022-09-13 | 2022-09-09 | PMVP | Jalota Deepika | SVP, Regulatory Affairs, QA | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 | |
| I | 2022-05-31 | 2022-05-26 | PMVP | OrbiMed Capital GP V LLC | 10% | S - Sale | $15.93 | -26.3K | 87.8K | -23% | -$418.2K |
| D | 2022-04-29 | 2022-04-27 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +33.0K | 80.0K | +70% | +$17.5K |
| D | 2022-04-21 | 2022-04-20 | PMVP | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,000 | 10.6K | +61% | +$12.9K |
| MI | 2022-03-31 | 2022-03-29+ | PMVP | OrbiMed Genesis GP LLC | 10% | S - Sale | $21.63 | -474.5K | 34.5K | -93% | -$10.26M |
| DMI | 2022-03-09 | 2021-03-09 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 80.0K | New | $0 |
| D | 2022-03-09 | 2022-03-08 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $1.37 | +20.0K | 47.0K | +74% | +$27.4K |
| 2022-02-08 | 2021-12-30 | PMVP | Kung Winston | COO, CFO | G - Gift | $0.00 | -2,725 | 6,600 | -29% | $0 | |
| D | 2021-12-16 | 2021-12-15 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +9,000 | 27.0K | +50% | +$4,770 |
| DMI | 2021-12-16 | 2021-12-09 | PMVP | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 187.9K | New | $0 |
| I | 2021-10-08 | 2021-10-06 | PMVP | Schroeder Thilo | Dir | S - Sale | $30.15 | -800 | 1.10M | -0.1% | -$24.1K |
| MI | 2021-10-04 | 2021-09-30+ | PMVP | Schroeder Thilo | Dir | S - Sale | $30.09 | -14.6K | 1.10M | -1% | -$439.8K |
| MI | 2021-09-29 | 2021-09-27+ | PMVP | Schroeder Thilo | Dir | S - Sale | $30.06 | -7,461 | 1.12M | -0.7% | -$224.3K |
| I | 2021-09-24 | 2021-09-22 | PMVP | Schroeder Thilo | Dir | S - Sale | $30.00 | -100 | 1.12M | -0.0% | -$3,000 |
| 2021-09-23 | 2021-09-22 | PMVP | LEVINE ARNOLD J | Dir | S - Sale | $30.00 | -3,500 | 409.8K | -0.8% | -$105.0K | |
| I | 2021-09-21 | 2021-09-17 | PMVP | Schroeder Thilo | Dir | S - Sale | $30.03 | -711 | 1.12M | -0.1% | -$21.4K |
| MI | 2021-09-13 | 2021-09-09+ | PMVP | Schroeder Thilo | Dir | S - Sale | $30.41 | -70.8K | 1.14M | -6% | -$2.15M |
| D | 2021-09-10 | 2021-09-09 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $30.25 | -100 | 0 | -100% | -$3,025 |
| D | 2021-09-10 | 2021-09-09 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +100 | 100 | New | +$390 |
| D | 2021-09-08 | 2021-09-07 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $30.25 | -3,900 | 0 | -100% | -$118.0K |
| D | 2021-09-08 | 2021-09-07 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +3,900 | 3,900 | New | +$15.2K |
| MI | 2021-09-02 | 2021-08-31+ | PMVP | Schroeder Thilo | Dir | S - Sale | $30.25 | -46.9K | 1.22M | -4% | -$1.42M |
| MI | 2021-08-30 | 2021-08-26+ | PMVP | Schroeder Thilo | Dir | S - Sale | $30.45 | -58.8K | 1.28M | -4% | -$1.79M |
| MI | 2021-08-25 | 2021-08-23+ | PMVP | Schroeder Thilo | Dir | S - Sale | $30.87 | -51.9K | 1.61M | -3% | -$1.60M |
| 2021-08-24 | 2021-08-23 | PMVP | LEVINE ARNOLD J | Dir | S - Sale | $29.50 | -3,500 | 413.3K | -0.8% | -$103.2K | |
| D | 2021-08-20 | 2021-08-19 | PMVP | Kung Winston | COO, CFO | M - OptEx | $3.22 | +5,000 | 6,600 | +312% | +$16.1K |
| D | 2021-08-20 | 2021-08-19 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +5,500 | 18.0K | +44% | +$2,915 |
| MI | 2021-08-20 | 2021-08-18+ | PMVP | Schroeder Thilo | Dir | S - Sale | $33.05 | -30.7K | 1.64M | -2% | -$1.01M |
| D | 2021-08-18 | 2021-08-17 | PMVP | Jalota Deepika | SVP, Regulatory Affairs, QA | M - OptEx | $3.53 | +2,896 | 2,896 | New | +$10.2K |
| D | 2021-08-18 | 2021-08-17 | PMVP | Jalota Deepika | SVP, Regulatory Affairs, QA | S - Sale+OE | $33.78 | -2,896 | 0 | -100% | -$97.8K |
| MI | 2021-08-17 | 2021-08-13+ | PMVP | Schroeder Thilo | Dir | S - Sale | $33.89 | -80.5K | 1.68M | -5% | -$2.73M |
| MI | 2021-08-12 | 2021-08-10+ | PMVP | Schroeder Thilo | Dir | S - Sale | $34.36 | -68.5K | 1.75M | -4% | -$2.35M |
| DM | 2021-08-10 | 2021-08-09 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $34.04 | -4,471 | 0 | -100% | -$152.2K |
| D | 2021-08-10 | 2021-08-09 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +4,000 | 4,000 | New | +$15.6K |
| MI | 2021-08-09 | 2021-08-05+ | PMVP | Schroeder Thilo | Dir | S - Sale | $36.23 | -77.7K | 1.84M | -4% | -$2.81M |
| MI | 2021-08-04 | 2021-08-02+ | PMVP | Schroeder Thilo | Dir | S - Sale | $35.05 | -96.1K | 1.95M | -5% | -$3.37M |
| D | 2021-08-04 | 2021-08-03 | PMVP | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,500 | 6,100 | +281% | +$14.5K |
| D | 2021-08-04 | 2021-08-03 | PMVP | Kung Winston | COO, CFO | S - Sale+OE | $33.82 | -4,500 | 1,600 | -74% | -$152.2K |
| MI | 2021-07-30 | 2021-07-28+ | PMVP | Schroeder Thilo | Dir | S - Sale | $35.75 | -11.0K | 1.99M | -0.6% | -$394.1K |
| MI | 2021-07-27 | 2021-07-23+ | PMVP | Schroeder Thilo | Dir | S - Sale | $35.91 | -17.4K | 2.01M | -0.9% | -$623.5K |
| MI | 2021-07-23 | 2021-07-21+ | PMVP | Schroeder Thilo | Dir | S - Sale | $35.82 | -18.9K | 2.02M | -0.9% | -$676.0K |
| D | 2021-07-22 | 2021-07-20 | PMVP | LEVINE ARNOLD J | Dir | S - Sale | $35.12 | -3,500 | 416.8K | -0.8% | -$122.9K |
| DM | 2021-07-22 | 2021-07-20+ | PMVP | Mack David Henry | Pres, CEO, Dir | S - Sale+OE | $35.75 | -27.8K | 12.5K | -69% | -$993.7K |
| DM | 2021-07-22 | 2021-07-20+ | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +27.8K | 13.5K | New | +$14.7K |
| MI | 2021-07-14 | 2021-07-13 | PMVP | Kliman Gilbert H | 10% | J - Other | $0.00 | +28.2K | 25.6K | New | $0 |
| 2021-07-14 | 2021-07-13 | PMVP | Kliman Gilbert H | 10% | J - Other | $0.00 | -500.0K | 4.47M | -10% | $0 | |
| D | 2021-07-08 | 2021-07-08 | PMVP | Kung Winston | COO, CFO | M - OptEx | $3.22 | +4,500 | 6,100 | +281% | +$14.5K |
| D | 2021-07-08 | 2021-07-08 | PMVP | Kung Winston | COO, CFO | S - Sale+OE | $33.75 | -4,500 | 1,600 | -74% | -$151.9K |
| DM | 2021-07-08 | 2021-07-07 | PMVP | Alland Leila | Chief Medical Off | S - Sale+OE | $32.30 | -4,000 | 2,049 | -66% | -$129.2K |
| D | 2021-07-08 | 2021-07-07 | PMVP | Alland Leila | Chief Medical Off | M - OptEx | $3.90 | +4,000 | 4,000 | New | +$15.6K |